Circle Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.3M | Sell |
177,287
-4,089
| -2% | -$472K | 0.3% | 26 |
|
|
2025
Q4 | $19.1M | Buy |
181,376
+19,145
| +12% | +$1.8M | 0.29% | 29 |
|
|
2025
Q3 | $13.6M | Sell |
162,231
-19,064
| -11% | -$1.57M | 0.27% | 29 |
|
|
2025
Q2 | $14.4M | Buy |
181,295
+145
| +0.1% | +$11.5K | 0.31% | 28 |
|
|
2025
Q1 | $16.3M | Sell |
181,150
-4,195
| -2% | -$392K | 0.37% | 23 |
|
|
2024
Q4 | $18.4M | Sell |
185,345
-718
| -0.4% | -$74K | 0.39% | 22 |
|
|
2024
Q3 | $21.1M | Sell |
186,063
-2,885
| -2% | -$343K | 0.47% | 20 |
|
|
2024
Q2 | $23.4M | Sell |
188,948
-1,447
| -0.8% | -$186K | 0.54% | 17 |
|
|
2024
Q1 | $25.1M | Sell |
190,395
-3,274
| -2% | -$404K | 0.62% | 16 |
|
|
2023
Q4 | $21.1M | Buy |
193,669
+18,388
| +10% | +$1.91M | 0.54% | 18 |
|
|
2023
Q3 | $18M | Buy |
175,281
+79,260
| +83% | +$8.54M | 0.45% | 20 |
|
|
2023
Q2 | $11.1M | Buy |
96,021
+126
| +0.1% | +$14.3K | 1.47% | 9 |
|
|
2023
Q1 | $10.2M | Buy |
95,895
+522
| +0.5% | +$56.4K | 1.48% | 9 |
|
|
2022
Q4 | $10.6M | Sell |
95,373
-2,050
| -2% | -$210K | 1.63% | 9 |
|
|
2022
Q3 | $8.39M | Buy |
97,423
+180
| +0.2% | +$16.1K | 1.38% | 10 |
|
|
2022
Q2 | $8.87M | Buy |
97,243
+207
| +0.2% | +$18.4K | 1.41% | 10 |
|
|
2022
Q1 | $7.96M | Sell |
97,036
-569
| -0.6% | -$44.9K | 1.05% | 14 |
|
|
2021
Q4 | $7.48M | Buy |
97,605
+6,210
| +7% | +$495K | 0.98% | 15 |
|
|
2021
Q3 | $6.87M | Buy |
91,395
+9
| +0% | +$684 | 0.99% | 14 |
|
|
2021
Q2 | $7.11M | Sell |
91,386
-2,002
| -2% | -$149K | 1.02% | 14 |
|
|
2021
Q1 | $6.87M | Sell |
93,388
-320,743
| -77% | -$23.7M | 1.1% | 13 |
|
|
2020
Q4 | $32.3M | Buy |
414,131
+4,792
| +1% | +$366K | 4.63% | 4 |
|
|
2020
Q3 | $32.4M | Buy |
409,339
+778
| +0.2% | +$60.9K | 5.35% | 4 |
|
|
2020
Q2 | $30.1M | Buy |
408,561
+66
| +0% | +$4.97K | 5.28% | 4 |
|
|
2020
Q1 | $30M | Buy |
408,495
+1,653
| +0.4% | +$130K | 5.85% | 4 |
|
|
2019
Q4 | $35.3M | Sell |
406,842
-888
| -0.2% | -$72.9K | 6.11% | 4 |
|
|
2019
Q3 | $32.8M | Buy |
407,730
+2,770
| +0.7% | +$222K | 6.97% | 4 |
|
|
2019
Q2 | $32.4M | Sell |
404,960
-1,201
| -0.3% | -$92K | 7.02% | 4 |
|
|
2019
Q1 | $32.2M | Buy |
406,161
+385,923
| +1,907% | +$28.9M | 7.23% | 4 |
|
|
2018
Q4 | $1.48M | Buy |
20,238
+744
| +4% | +$52.5K | 0.55% | 22 |
|
|
2018
Q3 | $1.32M | Buy |
19,494
+89
| +0.5% | +$5.67K | 0.42% | 27 |
|
|
2018
Q2 | $1.12M | Buy |
19,405
+101
| +0.5% | +$5.7K | 0.38% | 30 |
|
|
2018
Q1 | $1M | Sell |
19,304
-295
| -2% | -$15.9K | 0.36% | 29 |
|
|
2017
Q4 | $1.05M | Buy |
19,599
+2,761
| +16% | +$153K | 0.4% | 25 |
|
|
2017
Q3 | $1.03M | Buy |
16,838
+98
| +0.6% | +$5.94K | 0.42% | 24 |
|
|
2017
Q2 | $1.02M | Buy |
16,740
+337
| +2% | +$20.5K | 0.45% | 24 |
|
|
2017
Q1 | $994K | Buy |
16,403
+270
| +2% | +$16.4K | 0.48% | 22 |
|
|
2016
Q4 | $906K | Buy |
+16,133
| New | +$944K | 0.48% | 23 |
|
Other funds holding MRK
VCM
VPM
Circle Wealth Management's MRK Position: Q1 2026 in Review
Circle Wealth Management reduced its Merck (MRK) stake by 2.3% in Q1 2026, selling an estimated $472K and leaving 177,287 shares worth $21.3M. The position accounts for 0.3% of the portfolio, ranked #26.
Circle Wealth Management first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $35.3M in Q4 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Circle Wealth Management held 177,287 shares of Merck worth $21.3M as of Q1 2026.
- Circle Wealth Management sold 4,089 Merck shares in Q1 2026, an estimated $472K.
- Merck made up 0.3% of Circle Wealth Management's portfolio in Q1 2026, its #26 holding.
- Circle Wealth Management first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- Circle Wealth Management's Merck position peaked at $35.3M in Q4 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Circle Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.